Sage Journals: Discover world-class research

Abstract

Objectives: To discover the maximum risk acceptable to patients and clinicians for complications typical to endovascular interventions in the setting of proximal deep vein thrombosis (DVT) and post-thrombotic syndrome (PTS).

Design: This was an observational study comparing patient/clinician risk acceptances in interviews using validated Standard Gamble methodology.

Methods: 30 patients with previous DVT and 30 vascular clinicians were given a scenario describing a hypothetical case of a patient being managed with acute iliofemoral DVT and another with PTS. Subjects were asked to provide the maximum risk they would accept for individual complications to cure the condition. To interpret variability, the Venous Clinical Severity Score, SF-36 domains and VEINES-QoL for each patient were plotted against their risk acceptance for major bleeding in the DVT scenario.

Results: For the DVT scenario, patients accepted high median risks compared to clinicians for major bleeding (40% vs 5%, p < .001), bleeding at other sites (50% vs 5%, p < .001), damage to blood vessels (60% vs 5%, p < .001), further procedures (80% vs 20%, p < .001), and treatment failure (75–80% vs 10–20%, p < .001). However, the gap was lower for intracranial bleeding (5% vs 1%, p = .004), pulmonary embolism (5 vs 5%, p = .39) or death (1% vs 0.75%, p = .77). For the PTS scenario, there were similar results again with a lower difference for pulmonary embolism (10% vs 5%, p = .02) and death (0.5% vs 1%, p = .72). Importantly, patient risk acceptance for major bleeding was negatively correlated to the emotional wellbeing (Rho = −0.43, p = .018) and social functioning (Rho = −0.38, p = .042) SF-36 domains.

Conclusion: Overall, patients accepted a greater chance of most adverse events compared with clinicians. Patients prepared to accept greater risk were those with poorer emotional wellbeing and social functioning. It is important to take these issues into account when making shared decisions with patients about the management of their DVT/PTS.

Keywords

Venous insufficiency deep venous disease venous thrombosis postthrombotic syndrome complications

Get full access to this article

View all access options for this article.

References

Arshad

Isaksen

Hansen

, et al. Time trends in incidence rates of venous thromboembolism in a large cohort recruited from the general population. Eur J Epidemiol 2017; 32: 299–305.

Prandoni

Lensing

Cogo

, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1–7.

Stain

Schönauer

Minar

, et al. The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. J Thromb Haemostasis 2005; 3: 2671–2676.

Kahn

Shbaklo

Lamping

, et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. J Thromb Haemostasis 2008; 6: 1105–1112.

Kahn

Comerota

Cushman

, et al. The postthrombotic syndrome: evidence-based prevention, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation 2014; 130: 1636–1661.

Kahn

M’Lan

Lamping

, et al. The influence of venous thromboembolism on quality of life and severity of chronic venous disease. J Thromb Haemostasis 2004; 2: 2146–2151.

Ashrani

Heit

. Incidence and cost Burden of post-thrombotic syndrome. J Thromb Thrombolysis 2009; 28: 465–476.

Roberts

Patel

Donaldson

, et al. Post-thrombotic syndrome is an independent determinant of health-related quality of life following both first proximal and distal deep vein thrombosis. Haematologica 2014; 99: e41–e43.

Hull

Pineo

Brant

, et al. Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome. Am J Med 2009; 122: 762–769.e3.

10.

Kahn

Shapiro

Wells

, et al. Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial. Lancet 2014; 383: 880–888.

11.

Appelen

van Loo

Prins

, et al. Compression therapy for prevention of post-thrombotic syndrome. Cochrane Database Syst Rev 2017; 9: CD004174.

12.

Haig

Enden

Grøtta

, et al. Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. Lancet Haematol 2016; 3: e64–e71.

13.

Vedantham

Goldhaber

Julian

, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis. N Engl J Med 2017; 377: 2240–2252.

14.

Notten

de Smet

AAEA

Tick

, et al. CAVA (ultrasound-accelerated catheter-directed thrombolysis on preventing post-thrombotic syndrome) trial: long-term follow-up results. J Am Heart Assoc 2021; 10: e018973.

15.

Gafni

. The standard gamble method: what is being measured and how it is interpreted. Health Serv Res 1994; 29: 207–224.

16.

Morbi

AHM

Coles

Albayati

, et al. Understanding patient acceptance of risk with treatment options for intermittent claudication. Ann Vasc Surg 2017; 40: 223–230.

17.

Puhan

Schünemann

Wong

, et al. The standard gamble showed better construct validity than the time trade-off. J Clin Epidemiol 2007; 60: 1029–1033.

18.

Hoebel

von der Lippe

Lange

, et al. Mode differences in a mixed-mode health interview survey among adults. Arch Public Health 2014; 72: 46.

19.

Alex

GMJ

Wyrwich

. Health utility measures and the standard gamble. Acad Emerg Med 2003; 10: 360–363.

20.

Carradice

Mazari

Samuel

, et al. Modelling the effect of venous disease on quality of life. Br J Surg 2011; 98: 1089–1098.

21.

Chopard

Albertsen

Piazza

. Diagnosis and treatment of lower extremity venous thromboembolism: a review. JAMA 2020; 324: 1765–1776.

22.

Bass

Steinberg

Pitt

, et al. Comparison of the rating scale and the standard gamble in measuring patient preferences for outcomes of gallstone disease. Med Decis Mak 1994; 14: 307–314.

23.

Zafar

Harris

Murphy

, et al. Patients’ perspective about risks and benefits of treatment for peripheral arterial disease. J Vasc Intervent Radiol 2011; 22: 1657–1661.

24.

Catarinella

Nieman

FHM

Wittens

CHA

. An overview of the most commonly used venous quality of life and clinical outcome measurements. J Vasc Surg Venous Lymphat Disord 2015; 3: 333–340.

25.

Patrick

Deyo

. Generic and disease-specific measures in assessing health status and quality of life. Med Care 1989; 27: S217–S232.

26.

Makedonov

Kahn

Galanaud

. Prevention and management of the post-thrombotic syndrome. J Clin Med 2020; 9: 923.

27.

Javed

Machin

Gwozdz

, et al. Meta-analysis of lytic catheter-based intervention for acute proximal deep vein thrombosis in the reduction of post-thrombotic syndrome. J Vasc Surg Venous Lymphat Disord 2023; 11: 866–875.e1.

28.

Neglén

Hollis

Olivier

, et al. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg 2007; 46: 979–990.

29.

Ferreira

Oliveira-Pinto

Duarte-Gamas

, et al. Mid-term patency of iliac venous stenting for post-thrombotic syndrome. Int Angiol 2021; 40: 196–205.

30.

Kahn

Hirsch

Shrier

. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002; 162: 1144–1148.

31.

Catarinella

Nieman

FHM

Wittens

CHA

. The relation between clinical scores and quality-of-life in long-term follow-up. Phlebology 2016; 31: 99–105.

32.

Srikrishna

Robinson

Cardozo

, et al.

Is there a discrepancy between patient and physician quality of life assessment?

Neurourol Urodyn 2009; 28: 179–182.

33.

Barata

Martino

Gich

, et al.

Do patients and physicians agree when they assess quality of life?

Biol Blood Marrow Transplant 2017; 23: 1005–1010.

34.

Prichard

Zhao

Mcdonagh

, et al. Discrepancies between proxy estimates and patient reported, health related, quality of life: minding the gap between patient and clinician perceptions in heart failure. Qual Life Res 2021; 30: 1049–1059.

35.

Güneş

Sincer

Erdal

. Catheter-directed intra-arterial thrombolysis for lower extremity arterial occlusions. Anatol J Cardiol 2019; 22: 54–59.

36.

De Maeseneer

Kakkos

Aherne

, et al. Editor’s choice – European society for vascular surgery (ESVS) 2022 clinical practice guidelines on the management of chronic venous disease of the lower limbs. Eur J Vasc Endovasc Surg 2022; 63: 184–267.

37.

Scali

Rzucidlo

Bjerke

, et al. Long-term results of open and endovascular revascularization of superficial femoral artery occlusive disease. J Vasc Surg 2011; 54: 714–721.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.20 MB

Risk acceptance for deep venous interventions of the lower limb

Abstract

Keywords

Get full access to this article

References

Supplementary Material